Streetbeat News

Analyst Ratings

GMAB

Truist Securities has maintained a Buy rating on Genmab (NASDAQ:GMAB) but lowered the price target from $53 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:57 pm

YETI

Canaccord Genuity analyst Brian McNamara has maintained a Hold rating on YETI Holdings with a price target of $44.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:56 pm

ASO

Academy Sports and Outdoors, Inc. (NYSE:ASO) is set to report its Q2 earnings, with analysts expecting a slight decrease in EPS compared to last year. The company has a dividend yield of 0.82%, and investors would need significant investment to earn $500 monthly from dividends. Telsey Advisory Group maintains an Outperform rating with a $65 price target.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 1:50 pm

ABM

Truist Securities has maintained a Hold rating on ABM Industries while raising the price target from $49 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:48 pm

DOC

Scotiabank analyst Nicholas Yulico maintains a Sector Outperform rating on Healthpeak Properties and raises the price target from $23 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:48 pm

PTGX

Truist Securities has initiated coverage on Protagonist Therapeutics with a Buy rating and set a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:47 pm

NFLX

Financial giants are showing a bullish trend on Netflix (NASDAQ:NFLX) with 66% of options trades being bullish. Analysts have set high price targets, and the stock is currently up 1.18% at $673.6. The next earnings report is expected in 37 days.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

TSN

Barclays analyst Benjamin Theurer has maintained an Overweight rating on Tyson Foods and raised the price target from $72 to $76.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:44 pm

PPC

Barclays analyst Duffy Fischer maintains an Equal-Weight rating on Pilgrims Pride (NASDAQ:PPC) and raises the price target from $43 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:43 pm

PM

Barclays analyst Gaurav Jain has maintained an Overweight rating on Philip Morris International (NYSE:PM) and increased the price target from $130 to $145.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:42 pm